eltrombopag olamine (70069-840)

Drug Facts

Product Profile

Brand Name eltrombopag olamine

Generic Name eltrombopag olamine

Labeler somerset therapeutics, llc

Dosage Form TABLET, FILM COATED

Routes

ORAL

Active Ingredients

eltrombopag olamine 75 mg/1

Manufacturer

Somerset Therapeutics, LLC

Identifiers & Regulatory

Product NDC 70069-840

Product ID 70069-840_ec6939e2-4f64-4edd-848c-83e73ffac433

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA219638

Listing Expiration 2027-12-31

Marketing Start 2026-01-14

Pharmacologic Class

Classes

breast cancer resistance protein inhibitors [moa] increased megakaryocyte maturation [pe] increased platelet production [pe] organic anion transporting polypeptide 1b1 inhibitors [moa] thrombopoietin receptor agonist [epc] thrombopoietin receptor agonists [moa] ugt1a1 inhibitors [moa] ugt1a3 inhibitors [moa] ugt1a4 inhibitors [moa] ugt1a6 inhibitors [moa] ugt1a9 inhibitors [moa] ugt2b15 inhibitors [moa] ugt2b7 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70069840

Hyphenated Format 70069-840

Supplemental Identifiers

RxCUI

825421 825427 884617 1245001

UPC

0370069838013 0370069840016 0370069839010 0370069837016

UNII

4U07F515LG

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name eltrombopag olamine (source: ndc)

Generic Name eltrombopag olamine (source: ndc)

Application Number ANDA219638 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

75 mg/1

source: ndc

Packaging

30 TABLET, FILM COATED in 1 BOTTLE (70069-840-01)

source: ndc

Packages (1)

70069-840-01 30 TABLET, FILM COATED in 1 BOTTLE (70069-840-01)

Ingredients (1)

eltrombopag olamine (75 mg/1)

Linked Drug Pages (1)

Eltrombopag olamine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "ec6939e2-4f64-4edd-848c-83e73ffac433", "openfda": {"upc": ["0370069838013", "0370069840016", "0370069839010", "0370069837016"], "unii": ["4U07F515LG"], "rxcui": ["825421", "825427", "884617", "1245001"], "spl_set_id": ["604f663c-4933-402a-8105-5921713cf3c8"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (70069-840-01)", "package_ndc": "70069-840-01", "marketing_start_date": "20260114"}], "brand_name": "Eltrombopag olamine", "product_id": "70069-840_ec6939e2-4f64-4edd-848c-83e73ffac433", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Increased Megakaryocyte Maturation [PE]", "Increased Platelet Production [PE]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Thrombopoietin Receptor Agonist [EPC]", "Thrombopoietin Receptor Agonists [MoA]", "UGT1A1 Inhibitors [MoA]", "UGT1A3 Inhibitors [MoA]", "UGT1A4 Inhibitors [MoA]", "UGT1A6 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B15 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]"], "product_ndc": "70069-840", "generic_name": "Eltrombopag olamine", "labeler_name": "Somerset Therapeutics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eltrombopag olamine", "active_ingredients": [{"name": "ELTROMBOPAG OLAMINE", "strength": "75 mg/1"}], "application_number": "ANDA219638", "marketing_category": "ANDA", "marketing_start_date": "20260114", "listing_expiration_date": "20271231"}